Title |
Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’
|
---|---|
Published in |
BMC Infectious Diseases, January 2013
|
DOI | 10.1186/1471-2334-13-22 |
Pubmed ID | |
Authors |
Nawal Salahuddin, Farheen Ali, Zahra Hasan, Nisar Rao, Masooma Aqeel, Faisal Mahmood |
Abstract |
Vitamin D enhances host protective immune responses to Mycobacterium tuberculosis by suppressing Interferon-gamma (IFN-g) and reducing disease associated inflammation in the host. The objectives of this study were to determine whether vitamin D supplementation to patients with tuberculosis (TB) could influence recovery. |
X Demographics
The data shown below were collected from the profiles of 27 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 11% |
United Kingdom | 3 | 11% |
Kuwait | 2 | 7% |
Canada | 2 | 7% |
Peru | 1 | 4% |
Italy | 1 | 4% |
Spain | 1 | 4% |
Australia | 1 | 4% |
South Africa | 1 | 4% |
Other | 1 | 4% |
Unknown | 11 | 41% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 20 | 74% |
Practitioners (doctors, other healthcare professionals) | 6 | 22% |
Scientists | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 266 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | <1% |
Netherlands | 1 | <1% |
South Africa | 1 | <1% |
India | 1 | <1% |
New Zealand | 1 | <1% |
Spain | 1 | <1% |
Japan | 1 | <1% |
Unknown | 258 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 47 | 18% |
Student > Bachelor | 38 | 14% |
Researcher | 26 | 10% |
Student > Ph. D. Student | 24 | 9% |
Other | 20 | 8% |
Other | 54 | 20% |
Unknown | 57 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 101 | 38% |
Agricultural and Biological Sciences | 22 | 8% |
Biochemistry, Genetics and Molecular Biology | 16 | 6% |
Nursing and Health Professions | 12 | 5% |
Immunology and Microbiology | 12 | 5% |
Other | 40 | 15% |
Unknown | 63 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 May 2015.
All research outputs
#2,133,034
of 24,633,436 outputs
Outputs from BMC Infectious Diseases
#591
of 8,249 outputs
Outputs of similar age
#21,339
of 295,333 outputs
Outputs of similar age from BMC Infectious Diseases
#7
of 173 outputs
Altmetric has tracked 24,633,436 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,249 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 295,333 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 173 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.